FAFGX | LGRNX | FAFGX / LGRNX | |
Total Expense Ratio | 0.40 | 0.57 | 70% |
Annual Report Gross Expense Ratio | 0.40 | 0.57 | 70% |
Fund Existence | 5 years | 13 years | - |
Gain YTD | 15.758 | 11.194 | 141% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 1000000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 328B | 17.7B | 1,853% |
Annual Yield % from dividends | 0.52 | 0.00 | - |
Returns for 1 year | 16.13 | 20.85 | 77% |
Returns for 3 years | 56.46 | 64.74 | 87% |
Returns for 5 years | N/A | 41.55 | - |
Returns for 10 years | N/A | 212.22 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
MSMR | 32.61 | 0.14 | +0.43% |
McElhenny Sheffield Managed Risk ETF | |||
JPSV | 60.01 | 0.24 | +0.39% |
JPMorgan Active Small Cap Value ETF | |||
BME | 36.65 | N/A | N/A |
Blackrock Health Sciences Trust | |||
FARX | 25.84 | N/A | N/A |
Frontier Asset Absolute Return ETF | |||
NVDL | 89.01 | -1.54 | -1.70% |
GraniteShares 2x Long NVDA Daily ETF |